well what has management to say about that - time for an ANN IMO as this is quite sensitive to company. Lets now see what management say about other revenue streams to spread the risk - IMO no management performance bonuses should be paid due to this quite negative bit of news. Now management need to get their act into gear and get moving on projects - oh that's right what projects - from what I can determine none no where near commercialisation.
So if the news about FDA was in November why no ANN from management?????
Add to My Watchlist
What is My Watchlist?
